Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06443307
Status:
RECRUITING
Last Update Posted:
2024-06-05
First Post:
2024-05-15
Brief Title:
Real-world Study to Evaluate the Efficacy and Safety of Liposome Irinotecan
Sponsor:
Peking University
Organization:
Peking University
Study Overview
Official Title:
A Prospective Multi-cohort National Multicenter Real-world Study to Evaluate the Efficacy and Safety of Liposome Irinotecan
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a prospective multicenter real-world study There are four cohorts Cohorts 1-3 include second-line posterior-line and neoadjuvant colorectal cancer patients respectively Cohort 4 include patients with the exception of those with pancreatic and colorectal cancer As this study is a real-world investigation treatment procedures visit schedules and examinations will be based on the routine clinical practice of physicians Through the above cohort the efficacy and safety of irinotecan liposome are comprehensively observed
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None